no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants
|
Lee, Ping-Ing |
|
1995 |
13 |
17 |
p. 1685-1689 5 p. |
article |
2 |
Antigenic analysis of Japanese encephalitis viruses in Asia by using monoclonal antibodies
|
Hasegawa, Hitoshi |
|
1995 |
13 |
17 |
p. 1713-1721 9 p. |
article |
3 |
Calendar
|
|
|
1995 |
13 |
17 |
p. 1730- 1 p. |
article |
4 |
Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults
|
Rustgi, Vinod K. |
|
1995 |
13 |
17 |
p. 1665-1668 4 p. |
article |
5 |
Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120
|
Fouts, Timothy R. |
|
1995 |
13 |
17 |
p. 1697-1705 9 p. |
article |
6 |
Immunological parameters associated with antigenic competition in a multivalent footrot vaccine
|
Hunt, Jacqueline D. |
|
1995 |
13 |
17 |
p. 1649-1657 9 p. |
article |
7 |
Immunomodulatory effects of HSV2 glycoprotein D in HSV1 infected mice: implications for immunotherapy of recurrent HSV infection
|
York, Laura J. |
|
1995 |
13 |
17 |
p. 1706-1712 7 p. |
article |
8 |
Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms
|
Behboudi, Shahriar |
|
1995 |
13 |
17 |
p. 1690-1696 7 p. |
article |
9 |
Modified papilloma virus L2 protein; recombinant L2 protein preparation and virus-like particle assembly for use in a recombinant vaccine with no or little DNA present
|
|
|
1995 |
13 |
17 |
p. 1729- 1 p. |
article |
10 |
Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment
|
Cropley, I. |
|
1995 |
13 |
17 |
p. 1643-1648 6 p. |
article |
11 |
Myxoma virus as a vaccine vector for rabbits: antibody levels to influenza virus haemagglutinin presented by a recombinant myxoma virus
|
Kerr, Peter J. |
|
1995 |
13 |
17 |
p. 1722-1726 5 p. |
article |
12 |
New DNA encoding infectious rubella virus; reconstituted virus prepared from cDNA, optionally also including epitope sequences from other virus pathogens, for use in recombinant vaccine
|
|
|
1995 |
13 |
17 |
p. 1729- 1 p. |
article |
13 |
New mammalian expression systems for HCV proteins; hepatitis C virus recombinant E1 and E2 fusion protein preparation by vector plasmid pHCV-172, plasmid pHCV-351 and plasmid pHCV-425 expression for use in recombinant vaccine
|
|
|
1995 |
13 |
17 |
p. 1729- 1 p. |
article |
14 |
Overproduction of heterologous peptide in plants; influenza virus hemagglutinin 12CA5 or mouse zona pellucida-3 epitope expression in a transgenic plant using a tobacco-mosaic virus vector for use as a recombinant vaccine or contraceptive
|
|
|
1995 |
13 |
17 |
p. 1729- 1 p. |
article |
15 |
Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation
|
Babu, John Sam |
|
1995 |
13 |
17 |
p. 1669-1676 8 p. |
article |
16 |
Protection of ruminants by Pasteurella haemolytica A1 capsular polysaccharide vaccines containing muramyl dipeptide analogs
|
Brogden, Kim A. |
|
1995 |
13 |
17 |
p. 1677-1684 8 p. |
article |
17 |
Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States
|
Bernstein, Henry H. |
|
1995 |
13 |
17 |
p. 1631-1635 5 p. |
article |
18 |
Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis
|
Heinz, Franz X. |
|
1995 |
13 |
17 |
p. 1636-1642 7 p. |
article |
19 |
Serum and colostrum antibody responses induced by jet-injection of sheep with DNA encoding a Cryptosporidium parvum antigen
|
Jenkins, Mark |
|
1995 |
13 |
17 |
p. 1658-1664 7 p. |
article |
20 |
Urgent need for effective vaccine against Salmonella paratyphi A, B and C
|
Arya, S.C. |
|
1995 |
13 |
17 |
p. 1727-1728 2 p. |
article |